logo

For the Inventor, By the Inventor

Portage, MI, United States of America

Steven J Brickner

This inventor holds 24 USPTO granted patents, primarily in Antibacterial Compounds. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Pfizer Corporation. Active years: 1990-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven J Brickner. Retrieved from https://idiyas.com/inventor/steven-j-brickner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 91.7

Average Co-Inventor Count = 2.0

ph-index = 14

Forward Citations = 541(Granted Patents)


Location History:

  • Portage, MI (US) (1990 - 1999)
  • Niantic, CT (US) (1999)
  • Ledyard, CT (US) (1998 - 2017)

Company Filing History:

goldMedal12 out of 523 
 
Pharmacia & Upjohn Company
 patents
silverMedal8 out of 2,170 
 
The Upjohn Co.
 patents
bronzeMedal2 out of 4,490 
 
Pfizer Corporation
 patents
4. 1 out of 128 
 
Institut National De La Recherche Scientifique
 patents
5. 1 out of 3,080 
 
The General Hospital Corporation
 patents
6. 1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2017

Loading Chart...
Areas of Expertise:
Antibiotic Tolerance Inhibitors
Antimicrobials
Oxazolidinones
Spirocyclic Compounds
Bicyclic Compounds
Phenyloxazolidinones
Heteroaryl Compounds
Diazinyl Moieties
Thiazine Oxazolidinones
Substituted Compounds
Beta-Lactams
Fused-Ring Structures
24 patents (USPTO):Explore Patents
1. 9643933 - Compounds useful as antibiotic tolerance inhibitors (2017-05-09),
2. 8324198 - Monocarbams (2012-12-04),
3. 8252782 - Monocarbams (2012-08-28),
4. 6090820 - Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones (2000-07-18),
5. 5929248 - Substituted heteroarylphenyloxazolidinones (1999-07-27),
6. 5883093 - Phenyloxazolidinone antimicrobials (1999-03-16),
7. 5880118 - Substituted oxazine and thiazine oxazolidinone antimicrobials (1999-03-09),
8. 5801246 - Substituted heteroarylphenyloxazolidinones (1998-09-01),
9. 5756732 - Substituted heteroarylphenyloxazolidinones (1998-05-26),
10. 5719154 - Oxazolidinone antibacterial agents having a six-membrane heteroaromatic (1998-02-17),
11. 5708169 - 5-amidomethyl .alpha.,.beta.-saturated and -unsaturated 3-aryl (1998-01-13),
12. 5700799 - Oxazolidinone antimicrobials containing substituted diazine moieties (1997-12-23),
13. 5688792 - Substituted oxazine and thiazine oxazolidinone antimicrobials (1997-11-18),
14. 5654435 - Substituted arylphenyloxazolindinones (1997-08-05),
15. 5654428 - Substituted heteroarylphenyloxazolidinones (1997-08-05),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with that.

Title: The Inventive Achievements of Steven J Brickner from Portage, MI

Introduction: Steven J Brickner, a prolific inventor hailing from Portage, MI, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 24 patents.

Latest Patents: Brickner's recent patents include "Compounds Useful as Antibiotic Tolerance Inhibitors," which focuses on compounds and salts beneficial for treating chronic and acute bacterial infections, and "Monocarbams," which pertains to compounds essential in combating bacterial infections.

Career Highlights: Having worked at renowned companies such as Pharmacia & Upjohn Company and The Upjohn Co., Brickner has honed his skills and expertise in developing innovative pharmaceutical solutions. His patents reflect his dedication to advancing medical treatments.

Collaborations: Throughout his career, Brickner has collaborated with esteemed professionals in the industry, including Michael R Barbachyn and Douglas K Hutchinson. These collaborations have enriched his work and led to groundbreaking inventions.

Conclusion: Steven J Brickner's trailblazing work in the pharmaceutical sector stands as a testament to his innovative spirit and commitment to improving healthcare. His patents not only showcase his brilliance but also contribute significantly to the advancement of medical science.

If you have any more requests or need further details, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…